Use of Spatial Information to Predict Multidrug Resistance in Tuberculosis Patients, Peru
Hsien-Ho Lin, Sonya S. Shin, Carmen Contreras, Luis Asencios, Christopher J. Paciorek, and Ted Cohen
Author affiliations: Brigham and Women’s Hospital, Boston, Massachusetts, USA (H.H. Lin, S.S. Shin, T. Cohen); Mennonite Christian Hospital, Hualien, Taiwan (H.H. Lin); National Taiwan University, Taipei, Taiwan (H.H. Lin); Partners In Health, Boston (S.S. Shin); Socios En Salud Sucursal Peru, Lima, Peru (C. Contreras); Instituto Nacional de Salud, Lima (L. Asencios); Harvard School of Public Health, Boston (C.J. Paciorek, T. Cohen); University of California, Berkeley, California, USA (C.J. Paciorek)
Figure 2. . . . Receiver operating characteristic curves for the 4 prediction models for multidrug-resistant tuberculosis among patients who received drug susceptibility testing, Lima Ciudad and Lima Este, Peru, 2005–2007.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.